Bitte aktiviere Javascript und schalte etwaige Werbeblocker ab

Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

EQS-News: Formycon to present at the 42nd Annual J.P. Morgan Healthcare ConferencePhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D

EQS-News: Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference

EQS-News: Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference

0

DRIVEN BRANDS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline

DRIVEN BRANDS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline

DRIVEN BRANDS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline

0

INSPIRE MEDICAL INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Inspire Medical Investors of a Class Action Lawsuit and Upcoming DeadlinePhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

INSPIRE MEDICAL INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Inspire Medical Investors of a Class Action Lawsuit and Upcoming Deadline

INSPIRE MEDICAL INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Inspire Medical Investors of a Class Action Lawsuit and Upcoming Deadline

0

TUI AG: PUBLICATION OF CIRCULAR AND NOTICE OF PROPOSED UK DELISTING RESOLUTION: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png

TUI AG: PUBLICATION OF CIRCULAR AND NOTICE OF PROPOSED UK DELISTING RESOLUTION

TUI AG: PUBLICATION OF CIRCULAR AND NOTICE OF PROPOSED UK DELISTING RESOLUTION

0

TUI AG: NOTICE OF 2024 ANNUAL GENERAL MEETING: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png

TUI AG: NOTICE OF 2024 ANNUAL GENERAL MEETING

TUI AG: NOTICE OF 2024 ANNUAL GENERAL MEETING

0

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plcPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

0

EQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy Photo, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

EQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy

EQS-News: Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy

0

EQS-News: NEON EQUITY AG supports GORE German Office Real Estate in structuring and implementing the non-cash capital increase

EQS-News: NEON EQUITY AG supports GORE German Office Real Estate in structuring and implementing the non-cash capital increase

EQS-News: NEON EQUITY AG supports GORE German Office Real Estate in structuring and implementing the non-cash capital increase

0

Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31

Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31

Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31

0

u-blox module unlocks new automotive use casesPhoto, wide shot, wide-angle lens, Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.midjourneyapi.xyz/temp/568784d0-c41a-4663-ab01-91f29a370903.png

u-blox module unlocks new automotive use cases

u-blox module unlocks new automotive use cases

0

Nordea Bank Abp: Repurchase of own shares on 03.01.2024Photo, wide shot, wide-angle lens, soft focus, Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D

Nordea Bank Abp: Repurchase of own shares on 03.01.2024

Nordea Bank Abp: Repurchase of own shares on 03.01.2024

0

EQS-News: Abivax 2024 Financial Communication CalendarPhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D

EQS-News: Abivax 2024 Financial Communication Calendar

EQS-News: Abivax 2024 Financial Communication Calendar

0

Cairn Homes Plc: Transaction in Own SharesPhoto, wide shot, wide-angle lens, Toy manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/2788fcd3-d339-4592-8f5c-a3b9125dc61f.png

Cairn Homes Plc: Transaction in Own Shares

Cairn Homes Plc: Transaction in Own Shares

0

EQS-News: Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&IPhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

EQS-News: Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I

EQS-News: Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I

0

EQS-News: Nordex Group receives an order for 106 MW from Spain Photo, wide shot, wide-angle lens, Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.midjourneyapi.xyz/temp/568784d0-c41a-4663-ab01-91f29a370903.png

EQS-News: Nordex Group receives an order for 106 MW from Spain

EQS-News: Nordex Group receives an order for 106 MW from Spain

0

EQS-News: Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS) Photo, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D

EQS-News: Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

EQS-News: Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

0

Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDAPhoto, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D

Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA

Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA

0

EQS-News: GRENKE CONTINUES ITS PROFITABLE GROWTH PATH: EUR 2.6 BILLION IN NEW LEASING BUSINESS IN 2023Photo, wide shot, wide-angle lens, soft focus, Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D

EQS-News: GRENKE CONTINUES ITS PROFITABLE GROWTH PATH: EUR 2.6 BILLION IN NEW LEASING BUSINESS IN 2023

EQS-News: GRENKE CONTINUES ITS PROFITABLE GROWTH PATH: EUR 2.6 BILLION IN NEW LEASING BUSINESS IN 2023

0

Ad hoc announcement pursuant to Art. 53 LR - Jungfrau Railway Group - More than 1 million guests visit the Jungfraujoch - Top of Europe Photo, wide shot, wide-angle lens, Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/bda07ced-e79e-4489-b731-ada601660c8e.png

Ad hoc announcement pursuant to Art. 53 LR - Jungfrau Railway Group - More than 1 million guests visit the Jungfraujoch - Top of Europe

Ad hoc announcement pursuant to Art. 53 LR - Jungfrau Railway Group - More than 1 million guests visit the Jungfraujoch - Top of Europe

0

Fuller, Smith & Turner PLC: Transaction in Own SharesPhoto, wide shot, wide-angle lens, Retail store, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/5574eb69-dc38-42f3-aadd-6163ac8bd4a8.png

Fuller, Smith & Turner PLC: Transaction in Own Shares

Fuller, Smith & Turner PLC: Transaction in Own Shares

0

EQS-News: Evotec announces CEO transitionPhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

EQS-News: Evotec announces CEO transition

EQS-News: Evotec announces CEO transition

0

EQS-Adhoc: Evotec announces CEO transitionPhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

EQS-Adhoc: Evotec announces CEO transition

EQS-Adhoc: Evotec announces CEO transition

0

HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023Photo, wide shot, wide-angle lens, Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png

HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023

HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 225.03 as at 31 December 2023

0

Key Figures

31.12.2023Photo, wide shot, wide-angle lens, Private equity firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/2b695cca-48cb-4195-802a-e3385fb90ec0.png

Key Figures 31.12.2023

Key Figures 31.12.2023

0

EQS-Adhoc: Airbus reports share buyback transactions 21-27 December 2023Photo, wide shot, wide-angle lens, Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png

EQS-Adhoc: Airbus reports share buyback transactions 21-27 December 2023

EQS-Adhoc: Airbus reports share buyback transactions 21-27 December 2023

0